Venturi Wealth Management LLC Purchases 291 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Venturi Wealth Management LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,642 shares of the medical equipment provider’s stock after acquiring an additional 291 shares during the quarter. Venturi Wealth Management LLC’s holdings in Intuitive Surgical were worth $857,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Up 0.9 %

ISRG stock opened at $601.17 on Wednesday. The stock has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a 50-day moving average price of $561.88 and a 200-day moving average price of $522.27.

Analyst Ratings Changes

A number of analysts have recently issued reports on ISRG shares. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Barclays lifted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Royal Bank of Canada boosted their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.